comparemela.com

Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings

Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Canada ,Long Beach ,California ,United States ,China ,Japan ,Suling Zhao ,Caitlin Lowie ,David Rosenbaum ,Laura Williams ,Daniel Weiner ,Yang ,Amy Mosman ,Kevinj Martin ,Davidm Spiegel ,Fosun Pharma ,Susan Edelstein ,National Kidney Foundation ,Nasdaq ,Twitter ,Linkedin ,Drug Administration ,Ardelyx Inc ,Facebook ,Present Additional Data Supporting First In Class ,Chronic Kidney Disease ,Clinical Meetings ,Tenapanor Treatment Added ,Average Dailyp Area Under ,Treatment Response ,Tenapanor Categorized ,Post Hoc Analysis ,Patient Perception ,Exhibitor Showcase ,New Paradigm ,Rethinking Hyperphosphatemia Management ,Lisa Gutekunst ,New Drug Application ,Knight Therapeutics ,Media Contacts ,

comparemela.com © 2020. All Rights Reserved.